As everyone knows, COVID-19 is rampaging around the world. Besides China, many countries in the world have different degrees of epidemic. Europe has become the center of the global epidemic storm. Behind the epidemic, there is still a huge gap in the epidemic.

Huaxi Securities once said in the research report that the world needs to consume 500000 to 700000 nucleic acid detection kits every day, and the shortage of nucleic acid detection kits will become a global problem. Fortunately, China's detection reagents begin to go abroad while meeting the domestic demand. At present, the test kits produced by Chinese enterprises have also been supplied overseas. Recently, some Chinese enterprises have obtained the sales license in the United States.

Global daily consumption of more than 500000 detection reagents! Chinese enterprises begin to supply goods overseas! US sales license

According to observer.com, on the evening of March 18, BGI, a Chinese gene technology company, announced that its new coronavirus nucleic acid detection kit had started the EUA application of the US Food and Drug Administration (FDA). At present, the pre EUA has been officially accepted.

According to the novel coronavirus pneumonia related policy guidelines recently issued by the United States, FDA can allow the unapproved new applications of medical products or existing medical products to be used for diagnosis, treatment and prevention of life threatening diseases or situations when emergency products are unable to meet the demand in the US. Therefore, from March 17, 2020, BGI's test kit will be officially sold in the US clinical market.

Global daily consumption of more than 500000 detection reagents! Chinese enterprises begin to supply goods overseas! US sales license

It is understood that there is indeed a shortage of testing kits in the United States, and the lack of testing capacity has become the biggest problem for the United States to deal with the epidemic. At the beginning of the outbreak, the United States said it would test 1 million people for the new coronavirus within a week, but on Friday, the country only tested about 3600 new coronavirus. Finally, on March 5 local time, the United States acknowledged that it did not have enough testing agents to meet the demand.

As a result, the United States recently liberalized the import of related medical supplies, exempting a total of more than 100 Chinese medical related products from import fees, including masks, gloves, disinfectant wipes, sample collection containers, etc. Recently, the United States has also imported 500000 test swabs from Italy, the most serious epidemic in Europe, to collect samples.

Global daily consumption of more than 500000 detection reagents! Chinese enterprises begin to supply goods overseas! US sales license

In contrast, in China, the epidemic situation has been gradually controlled. All the confirmed cases on March 19 were imported cases, and none of them were new cases in China. At the same time, the test kits developed and produced by Chinese enterprises have been exported to overseas markets. For example, the test kits of BGI have completed the EU CE certification and obtained the EU free sale certificate before entering the US market.

As of March 2, BGI has completed the production of more than 1.2 million test kits, which have been sent to 26 countries and regions. The virus detection kit developed by Zhijiang bio has been exported to more than 30 countries, including Italy, France, Germany, Japan and South Korea.

After meeting its own needs, China has begun to export some medical materials urgently needed by foreign countries. Up to now, a number of Chinese listed companies, including Anke biology, Kehua biology, lanfan medical, Yan'an Bikang, Kerui technology, Guoen shares, yinbaoshan new, have disclosed their product export information, involving virus detection, protective equipment, mask machines, etc.

Global daily consumption of more than 500000 detection reagents! Chinese enterprises begin to supply goods overseas! US sales license

At the same time, the technology of detection kit in China is making rapid progress, producing more efficient and simple detection kit. According to observer.com, the rapid detection kit for IgM and IgG double antibodies of coronavirus developed by Jiekang biology takes fingertip blood as the test sample, and the results can be obtained in 1-3 minutes without the operation of professional P2 laboratory testing and professional testing technicians. It is suitable for on-site screening of large population and rapid examination of fever clinics in major hospitals.

Special statement: the content of the above article only represents the author's own point of view, and does not represent Sina's point of view or position. If you have any questions about the content, copyright or other aspects of the work, please contact sina.com within 30 days after the publication of the work.